Detalles de la búsqueda
1.
Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system.
Onkologie
; 33(4): 155-66, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20389141
Resultados
1 -
1
de 1
1
Próxima >
>>